SC
GMAB icon

Syon Capital’s Genmab GMAB Stock Holding History

Syon Capital’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$212K Buy
7,900
+408
+5% +$12.2K 0.01% 865
2025
Q4 		$231K Buy
7,492
+120
+2% +$3.74K 0.01% 828
2025
Q3 		$226K Buy
+7,372
New +$180K 0.01% 752
2023
Q4 		– Sell
-9,414
Closed -$332K – 493
2023
Q3 		$332K Buy
+9,414
New +$359K 0.04% 255

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Syon Capital's GMAB Position: Q1 2026 in Review

Syon Capital increased its Genmab (GMAB) stake by 5.4% in Q1 2026, buying an estimated $12.2K and bringing the position to 7,900 shares worth $212K. The position accounts for 0.01% of the portfolio, ranked #865.

Syon Capital first reported a position in GMAB in Q3 2023 and has held it in 4 quarters since. The position peaked at $332K in Q3 2023. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Syon Capital held 7,900 shares of Genmab worth $212K as of Q1 2026.
  • Syon Capital bought 408 Genmab shares in Q1 2026, an estimated $12.2K.
  • Genmab made up 0.01% of Syon Capital's portfolio in Q1 2026, its #865 holding.
  • Syon Capital first reported a position in Genmab in Q3 2023 and has held it in 4 quarters since.
  • Syon Capital's Genmab position peaked at $332K in Q3 2023.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.